Related references
Note: Only part of the references are listed.Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma
Martin Lang et al.
UROLOGY (2021)
Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187
Zhonghao Wang et al.
ONCOGENESIS (2020)
MiTF is Associated with Chemoresistance to Cisplatin in A549 Lung Cancer Cells via Modulating Lysosomal Biogenesis and Autophagy
Wei Li et al.
CANCER MANAGEMENT AND RESEARCH (2020)
MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer
Ethan L. Morgan et al.
PLOS PATHOGENS (2020)
MicroRNA-218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2A
Ruojing Wei et al.
ONCOLOGY LETTERS (2019)
Pan-Renal Cell Carcinoma classification and survival prediction from histopathology images using deep learning
Sairam Tabibu et al.
SCIENTIFIC REPORTS (2019)
The YAP1-NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target
Wonbeak Yoo et al.
CANCERS (2019)
MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers
Jimyung Seo et al.
CANCER RESEARCH (2019)
Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism
D. Meng et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma
Wantae Kim et al.
GUT (2018)
SKP2 and OTUD1 govern non-proteolytic ubiquitination of YAP that promotes YAP nuclear localization and activity
Fan Yao et al.
CELL STRESS (2018)
The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology
Akinori Kawakami et al.
LABORATORY INVESTIGATION (2017)
Dysregulated Expression of MITF in Subsets of Hepatocellular Carcinoma and Cholangiocarcinoma
Nattakarn Nooron et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Up-regulation of CIT promotes the growth of colon cancer cells
Zehua Wu et al.
ONCOTARGET (2017)
Identification, genetic testing, and management of hereditary melanoma
Sancy A. Leachman et al.
CANCER AND METASTASIS REVIEWS (2017)
Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway
Ursula Ehmer et al.
MOLECULAR CANCER RESEARCH (2016)
Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth
L. Li et al.
ONCOGENE (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation
Yangfan Qi et al.
NATURE COMMUNICATIONS (2016)
Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism
RushikaM. Perera et al.
NATURE (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
Radiotherapy for renal-cell carcinoma
Gert De Meerleer et al.
LANCET ONCOLOGY (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Hippo Signaling Mediates Proliferation, Invasiveness, and Metastatic Potential of Clear Cell Renal Cell Carcinoma
Ute Schuette et al.
TRANSLATIONAL ONCOLOGY (2014)
Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4
Qing Bo Huang et al.
PLOS ONE (2013)
Citron kinase controls a molecular network required for midbody formation in cytokinesis
Zuni I. Bassi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Deregulation of Hippo kinase signalling in Human hepatic malignancies
Hua Li et al.
LIVER INTERNATIONAL (2012)
YAP is a candidate oncogene for esophageal squamous cell carcinoma
Tomoki Muramatsu et al.
CARCINOGENESIS (2011)
Sticky/Citron kinase maintains proper RhoA localization at the cleavage site during cytokinesis
Zuni I. Bassi et al.
JOURNAL OF CELL BIOLOGY (2011)
The Hippo Pathway in Biological Control and Cancer Development
Siew Wee Chan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Corine Bertolotto et al.
NATURE (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
X. Zhang et al.
ONCOGENE (2011)
The Hippo-YAP pathway: new connections between regulation of organ size and cancer
Bin Zhao et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Renal carcinoma associated with MiTF/TFE translocation: Report of six cases in young adults
M. -C. Hintzy et al.
PROGRES EN UROLOGIE (2008)
Cell type-specific functions of Rho GTPases revealed by gene targeting in mice
Lei Wang et al.
TRENDS IN CELL BIOLOGY (2007)
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
Suzanne Carreira et al.
GENES & DEVELOPMENT (2006)
Targeted therapy for metastatic renal cell carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
Keith S. Hoek et al.
PIGMENT CELL RESEARCH (2006)
MITF: master regulator of melanocyte development and melanoma oncogene
Carmit Levy et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Biochemical and molecular markers in renal cell carcinoma: an update and future prospects
MK Kashyap et al.
BIOMARKERS (2005)
Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression
S Carreira et al.
NATURE (2005)
Von Hippel-Lindau tumor suppressor protein stimulation by thrombin involves RhoA activation
S Turcotte et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF
JY Du et al.
CANCER CELL (2004)
Rho GTPases in cell biology
S Etienne-Manneville et al.
NATURE (2002)
Share Paper
